These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6800467)

  • 1. Rubella screening and immunisation of schoolgirls: results six to seven years after vaccination.
    Zealley H; Edmond E
    Br Med J (Clin Res Ed); 1982 Feb; 284(6313):382-4. PubMed ID: 6800467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA; Heywood SN; Laughton E; Gould JJ; Freestone DS
    J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella vaccination: persistence of antibodies for up to 16 years.
    O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):253-5. PubMed ID: 6807437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubella vaccination in Australia: 2. Experience with the RA27/3 rubella vaccine and results of a double-blind trial in schoolgirls.
    Menser MA; Forrest JM; Bransby RD; Collins E
    Med J Aust; 1978 Jul; 2(3):85-8. PubMed ID: 362141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.
    Macdonald H; Tobin JO; Cradock-Watson JE; Lomax J
    J Hyg (Lond); 1978 Jun; 80(3):337-47. PubMed ID: 649946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubella vaccination in Australia: 1. A five-year follow-up of vaccinated schoolgirls.
    Menser MA; Forrest JM; Bransby RD
    Med J Aust; 1978 Jul; 2(3):83-5. PubMed ID: 713933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubella viraemia and antibody responses after rubella vaccination and reimmunization.
    Balfour HH; Groth KE; Edelman CK; Amren DP; Best JM; Banatvala JE
    Lancet; 1981 May; 1(8229):1078-80. PubMed ID: 6112449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley.
    Freestone DS; Reynolds GM; McKinnon JA; Prydie J
    Br J Prev Soc Med; 1975 Dec; 29(4):258-61. PubMed ID: 766879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women.
    Tingle AJ; Mitchell LA; Grace M; Middleton P; Mathias R; MacWilliam L; Chalmers A
    Lancet; 1997 May; 349(9061):1277-81. PubMed ID: 9142061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of congenital rubella in Iceland by antibody screening and immunization of seronegative females.
    Gudmundsdóttir S; Antonsdóttir A; Gudnadóttir S; Elefsen S; Einarsdóttir B; Olafsson O; Gudnadóttir M
    Bull World Health Organ; 1985; 63(1):83-92. PubMed ID: 3872738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubella serology by solid-phase radioimmunoassay: its potential for screening programmes.
    Sugishita C; O'Shea S; Best JM; Banatvala JE
    Clin Exp Immunol; 1978 Jan; 31(1):50-4. PubMed ID: 639348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to rubella in women of childbearing age in the United Kingdom.
    Noah ND; Fowle SE
    BMJ; 1988 Nov; 297(6659):1301-4. PubMed ID: 3144367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubella immunisation and immunity in a defined population.
    Paul CE; Poole ES
    N Z Med J; 1983 Jul; 96(736):557-60. PubMed ID: 6575294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella: immunity and vaccination in schoolgirls.
    Kudesia G; Robinson ET; Wilson WD; Wilson TS; Stewart IM; Campbell AT; Thomson W; Silver M; Reid D; Urquhart GE
    Br Med J (Clin Res Ed); 1985 May; 290(6479):1406-8. PubMed ID: 3922513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rubella vaccination with "Cendehill" and "RA 27/3". Reinfection of vaccinated and naturally immune persons compared with the infection rate of susceptible persons within a 3-resp. 5-year observation period (author's transl)].
    Thomssen R
    Zentralbl Bakteriol Orig A; 1976 Nov; 236(2-3):163-84. PubMed ID: 1015009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.